Professionals‎ > ‎

wetenschappelijk



Wetenschap en onderzoek naar naaldangst en prikweerstand


Wetenschap en praktijk

Afgelopen decennia zijn er uiteenlopende onderzoeken geweest naar problemen rondom het prikken met de naald. In Engeland zijn daaruit voortkomend wetenschappelijke richtlijnen ontwikkeld hoe naaldangst bij kinderen te benaderen [10, 11]. Het implementeren van deze richtlijnen gaat erg traag [61]. Ook in Nederland is er helaas weinig wetenschappelijke inbedding in de praktijk bekend. Hier is dus nog veel ruimte en noodzaak voor verbetering.


Wetenschappelijke artikelen

Hieronder vindt u een aanzienlijke lijst met wetenschappelijke literatuur zo die deels gebruikt is voor het handboek Naaldangst en Prikweerstanden (in press).

[1] P. Szmuk, E. Szmuk, and T. Ezri, “Use of needle-free injection systems to alleviate
needle phobia and pain at injection,” Expert Review of Pharmacoeconomics &
Outcomes Research, vol. 5, no. 4, pp. 467–477, Aug. 2005.
[2] J. Hamilton, “Needle phobia neglected diagnosis.” 1995.
[3] G. J. Andrews and D. Shaw, “‘So we started talking about a beach in Barbados’:
Visualization practices and needle phobia,” Social Science & Medicine, vol. 71,
no. 10, pp. 1804–1810, Nov. 2010.
[4] A. P. Asociation, DSM IV, Diagnostic and Statistical Manual. 1994.
[5] B. P. N. Wickramasuriya, A. Casey, S. Akhtar, R. Zia, S. Ehtisham, T. G. Barrett, N.
J. Shaw, and J. M. W. Kirk, “Factors determining patient choice of device for GH
therapy,” Hormone research, vol. 65, no. 1, pp. 18–22, Jan. 2006.
[6] P. P. Network, Y. People, and B. P. Society, “Evidence-based Guidelines for the
Management of Invasive and / or Distressing Procedures with Children,” no.
October, 2009.
[7] R. R. Kapoor, S. a Burke, S. E. Sparrow, I. a Hughes, D. B. Dunger, K. K. Ong, and C.
L. Acerini, “Monitoring of concordance in growth hormone therapy,” Archives of
disease in childhood, vol. 93, no. 2, pp. 147–8, Feb. 2008.
[8] “Guidance on the Use of Human Growth Hormone (Somatropin) in Children
with Growth Failure,” Technology Appraisal Guidance, 2002
[9] WHO, “Injection safety,” Report by the secretariat. Health Organization Executive
Board, vol. 107th Sess, 2000.
[10] Network, Paediatric Psychology People, Young Society, British Psychological,
Evidence-based Guidelines for the Management of Invasive and / or
Distressing Procedures with Children,” October, 2009.
[11] a. J. a. Duff, S. L. Gaskell, K. Jacobs, and J. M. Houghton, “Management of
distressing procedures in children and young people: time to adhere to the
guidelines,” Archives of Disease in Childhood, vol. 97, no. 1, pp. 1–4, Nov. 2011.
[12] C. et. al. Bennett, “The Occurrence and of High Adolescents Levels of Acute
Behavioral Distress Undergoing Routine Venipunctures in Children,” vol. 90, no.
1, pp. 87–91, 1992.
[13] A. Hermann, A. Schäfer, B. Walter, R. Stark, D. Vaitl, and A. Schienle, “Diminished
medial prefrontal cortex activity in blood-injection-injury phobia.,” Biological
psychology, vol. 75, no. 2, pp. 124–30, May 2007.
130
[14] E. S. Ayala, A. E. Meuret, and T. Ritz, “Treatments for blood-injury-injection
phobia: a critical review of current evidence.,” Journal of psychiatric research,
vol. 43, no. 15, pp. 1235–42, Oct. 2009.
[15] Wieling, Ganzeboom & Saul Reflex syncope in children and adolescents (2004)
Heart. 2004 September; 90(9): 1094–1100
[16] Bracha, H. (2006). “Human brain evolution and the “Neuroevolutionary Timedepth
Principle:” Implications for the Reclassification of fear-circuitry-related
traits in DSM-V and for studying resilience to warzone-related posttraumatic
stress disorder”. Progress in Neuro-Psychopharmacology and Biological
Psychiatry 30 (5): 827–853
[17] M. van Overveld, P. J. de Jong, and M. L. Peters, “The Multi-Dimensional Blood/
Injury Phobia Inventory: its psychometric properties and relationship with
disgust propensity and disgust sensitivity,” Journal of anxiety disorders, vol. 25,
no. 3, pp. 319–25, Apr. 2011.
[18] Woody & Teachman, “Intersection of disgust and fear: normative and
pathological views,” Clinical Psychology, Science and Practice, vol. 7, pp.
291–311, 2000.
[19] T. C. Tolin, D.F., Lohr, J.M., Sawchuk, C.N., Lee, “Disgust and disgust sensitivity in
blood-injection-injury and spider phobia,” Behaviour Research and Therapy,
vol. 35, pp. 949–953, 1997.
[20] E. L. Grunau, V.E., Whitfield, M.F., Petrie, J.H., Fryer, “Early pain experience, child
and family factors, as precursors of somatization: a prospective study of
extremely premature and fullterm children,” Pain, vol. 56, no. 3, pp. 353–359,
1994.
[21] Schouw R.H.J.A., Vroege pijn, kijk uit voor de hersenen! Lange-termijn effecten
van neontale pijn ervaringen. Proefschrift, Erasmus Universiteit Rotterdam.
[22] A. Buskila, D., Neuman, L., Zmora E., Feldman, M., Bolotin, “Pain sensitivity in
premature born Adolecents,” Arch Pediatric Adolsc Md, vol. 157, pp. 1079–1089,
2003.
[23] H. Hermann, C., Hofmeister, J., Demrakca, S., Zohsel K., Flor, “Long-term
alteration of pain sensitivity in school-aged children with early pain
experiences,” Pain, vol. 125, no. 3, pp. 278–285, 2006.
[24] J. Hands, C., Round, J., Thomas, “When someone stabs you: children’s
perspectives of venepuncture,” Arch Dis Child, vol. 94, p. 499, 2009.
[25] R. Hanas and J. Ludvigsson, “Experience of pain from insulin injections and
needle-phobia in young patients with IDDM,” Practical Diabetes International,
vol. 14, no. 4, pp. 95–99, 1997.
[26] D. Cox and J. Stone, “Managing Self-Injection Diffculties in Patients with
Relapsing-Remitting Multiple Sclerosis,” Journal of Neuroscience Nursing, vol.
38, no. 3, pp. 167–171, Jun. 2006.

[27] S. A. Counseling, D. C. Mohr, D. Ph, D. Cox, D. Psy, and A. Boudewyn, “SELF-
INJECTION ANXIETY COUNSELING ( SIAC ) MANUAL FOR COUNSELORS For
Use with the Patient Workbook,” pp. 1–36, 2003.
[28] Cloughertry, “For parents Overcoming a fear of needles.” 2003.
[29] D. C. Mohr, D. Ph, D. Cox, and D. Psy, “LEARNING TO SELF-INJECT : APPROACH
TO OVERCOMING INJECTION ANXIETY University of California San Francisco,”
2003.
[30] D. C. Mohr, a C. Boudewyn, W. Likosky, E. Levine, and D. E. Goodkin, “Injectable
medication for the treatment of multiple sclerosis: the influence of self-effcacy
expectations and injection anxiety on adherence and ability to self-inject,”
Annals of behavioral medicine : a publication of the Society of Behavioral
Medicine, vol. 23, no. 2, pp. 125–32, Jan. 2001.
[31] C. N. E. Tompkins, S. Ghoneim, N. M. J. Wright, L. Sheard, and L. Jones, “Needle
fear among women injecting drug users: a qualitative study,” Journal of
Substance Use, vol. 12, no. 4, pp. 281–291, Jan. 2007.
[32] J. Van den Berg, Bloednerveus en Prikkelende Oplossingen: gratis
informatieboek voor mensen met een angst en afkeer van bloed, verwondingen
en naalden. Angstbehandelcentrum IPZO, 2012.
[33] Website Rijksoverheid, http://www.rijksoverheid.nl/onderwerpen/mexicaansegriep/
vaccinatie-mexicaanse-griep
[34] WHO, “Injection safety,” vol. Fact sheet, 2006.
[35] Y. Nir, A. Paz, E. Sabo, and I. Potasman, “FEAR OF INJECTIONS IN YOUNG
ADULTS : PREVALENCE AND ASSOCIATIONS,” vol. 68, no. 3, pp. 341–344, 2003.
[36] C. CG., “Fears and phobias in women: a community study,” J. Abnorm. Psychol.
91, pp. 280–286, 1982.
[37] W.O. Arvidsson SB, Ekroth RH, Hansby AM, Lindholm AH, “Painless
venipuncture. A clinical trial of iontophoresis of lidocaine for venipuncture in
blood donors,” Acta Anaesthesiol. Scand, vol. 28, pp. 209–10, 1984.
[38] G. J. Oswalt R, “Blood donor motivation: a survey of minority college students,”
Psychol. Rep., vol. 72, pp. 785–786, 1993.
[39] E. W. Bienvenu OJ, “The epidemiology of blood- injection-injury phobia.,”
Psychol Med, vol. 28, pp. 1129–1136, 1998.
[40] D. H. Antony, M. M., Brown, T. A., & Barlow, “Heterogeneity among specific
phobia types in DSM-IV,” Behaviour Research and Therapy, vol. 35 (12), pp.
1089–1100, 1997.
[41] O. D. Agras S, Sylvester D, “The epidemiology of common fears and phobia,”
Comprehensive chiat, vol. 10, pp. 151–56, 1969.
[42] M. Vika, M. Raadal, E. Skaret, and G. Kvale, “Dental and medical injections:
prevalence of self-reported problems among 18-yr-old subjects in Norway,”
European Journal of Oral Sciences, vol. 114, no. 2, pp. 122–127, Apr. 2006.

[43] S. Finger, Origins of Neuroscience: A History of Explorations Into Brain Function.
Oxford University Press, 1994.
[44] J. Fenster, Ether Day: The Strange Tale of America’s Greatest Medical Discovery
and the Haunted Men Who Made It. York, HarperCollins, 2001.
[45] N. J. Cuper, R. M. Verdaasdonk, R. de Roode, and E. Septer, “Development
and clinical trial of a practical vessel imaging system for vessel punctures in
children,” Proceedings of SPIE, vol. 6848, pp. 684806–684806–10, 2008.
[46] K. J. Zengerink I, Brink PR, Laupland KB, Raber EL, Zygun D, “Needle
thoracostomy in the treatment of a tension pneumothorax in trauma patients:
what size needle?,” J Trauma, vol. 64 (1), pp. 111–4, 20087.
[47] G. H. Verrips, R. a Hirasing, M. Fekkes, T. Vogels, S. P. Verloove-Vanhorick, and H.
a Delemarre-Van de Waal, “Psychological responses to the needle-free Medi-
Jector or the multidose Disetronic injection pen in human growth hormone
therapy,” Acta paediatrica (Oslo, Norway : 1992), vol. 87, no. 2, pp. 154–8, Feb.
1998.
[48] C. M. G. J. Houtzagers, Insuline delivery Systems. Calff & Meischke, 1989, p. 120.
[49] M. K. (eds) Newman S, Steed L, Chronic physical ilness: Self-management and
behavioural interventions. Open University Press, 2009.
[50] R. A. Kleinknecht, “Dimensions of blood/injury and medically related fears:
development of the Medical Fears Survey,” Paper presented to the 25th Annual
Meeting of the Association for Advancement of Behavior Therapy, New York,
1991.
[51] K. Page, A. C., Bennett, K. S., Carter, O., Smith, J., & Woodmore, “The blood-
injection symptom scale (BISS): assessing a structure of phobic symptoms
elicited by blood and injections,” Behaviour Research and Therapy, vol. 35, pp.
457–464, 1997.
[52] A. Öst, L.-G., Hellström, K., & Käver, “One versus five sessions of exposure in the
treatment of injection phobia,” Behavior Therapy, vol. 23, pp. 263–282, 1992.
[53] H. de Jong, P., & Merckelbach, “Blood-injection-injury phobia and fear of spi-
ders: domain specific individual differences in disgust sensitivity,” Personality
and Individual Differences, vol. 24, pp. 153–158, 1998.
[54] L. Yim, “Belonephobia,” vol. 35, no. 8, pp. 623–624, 2006.
[55] RIVM, “Vacinatie Programma Rijksoverheid.” [Online]. Available: http://www.
rivm.nl/Onderwerpen/Onderwerpen/R/Rijksvaccinatieprogramma/De_
inenting/Vaccinatieschema?gclid=CIjF5JaU3bICFUPHtAodwx8ArQ.
[56] S. Aspects, “Adolescents ’ Compliance with Therapeutic Regimens,” pp. 52–67,
1987.
[57] T. E. D. & P. C. Wolfram R.W., “Effects of parental presence during young children’s
venepuncture,” Pediatric Emergency Care, vol. 13, pp. 325–358, 1997.

[58] R. L. Blount, B. Landolf-Fritsche, S. W. Powers, and J. W. Sturges, “Differences
Between High and Low Coping Children and Between Parent and Staff
Behaviors During Painful Medical Procedures,” Journal of Pediatric Psychology,
vol. 16, no. 6, pp. 795–809, 1991.
[59] G. E. Gunter, R. W., & Bodner, “How eye movements affect unpleasant
memories: Support for a working memory account.,” Behaviour Research and
Therapy, vol. 46, pp. 913–931, 2008.
[60] T. I. Usichenko, D. Pavlovic, S. Foellner, and M. Wendt, “Reducing Venipuncture
Pain by a Cough Trick: A Randomized Crossover Volunteer Study,” Anesthesia &
Analgesia, pp. 343–345, Feb. 2004.
[61] A. J. A. Duff, S. L. Gaskell, K. Jacobs, and J. M. Houghton, “Management of
distressing procedures in children and young people : time to adhere to the
guidelines PAEDIATRIC PSYCHOLOGY NETWORK,” 2011.
[62] S. L. Eds. . Bergin, A. E., & Garfield, Handbook of psychotherapy and behavior
change, 5th ed. New York: John Wiley & Sons, 1994.
[63] B. P. Klok T, Sulkers EJ, Kaptein AA, Duiverman EJ, “Therapietrouw bij chronisch
zieken. Patiëntgerichte benadering is noodzakelijk,” Ned. Tijdschrift Geneeskd,
p. 153:A420, 2009.
[64] S. C. Kettwich, W. L. Sibbitt, J. R. Brandt, C. R. Johnson, C. S. Wong, and a. D.
Bankhurst, “Needle Phobia and Stress-Reducing Medical Devices in Pediatric
and Adult Chemotherapy Patients,” Journal of Pediatric Oncology Nursing, vol.
24, no. 1, pp. 20–28, Jan. 2007.
[65] B. P. N. Wickramasuriya, a Casey, S. Akhtar, R. Zia, S. Ehtisham, T. G. Barrett, N. J.
Shaw, and J. M. W. Kirk, “Factors determining patient choice of device for GH
therapy,” Hormone research, vol. 65, no. 1, pp. 18–22, Jan. 2006.
[66] R. R. Kapoor, S. a Burke, S. E. Sparrow, I. a Hughes, D. B. Dunger, K. K. Ong, and C.
L. Acerini, “Monitoring of concordance in growth hormone therapy,” Archives of
disease in childhood, vol. 93, no. 2, pp. 147–8, Feb. 2008.
[67] “Guidance on the Use of Human Growth Hormone (Somatropin) in Children
with Growth Failure,” Technology Appraisal Guidance, 2002.
[68] S. Masud, R. D. Wasnich, J. L. Ruckle, W. T. Garland, S. W. Halpern, D. Mee-
Lee, M. a Ashburn, and J. C. Campbell, “Contribution of a heating element
to topical anesthesia patch effcacy prior to vascular access: results from
two randomized, double-blind studies.,” Journal of pain and symptom
management, vol. 40, no. 4, pp. 510–9, Oct. 2010.
[69] P. Thom, A., Sartory, G. & Johren, “Comparison between one-session
psychological treatment and benzodiazepine in dental phobia,” Journal of
Consulting and Clinical Psychology, vol. 68, pp. 378–387, 2000.
[70] & W. M. . Antony M.M., Ovecoming medical phobias. New Harbinger
Publications, Inc, 2006.
[71] Kaptein A, “De patient de baas, in Therapietrouw is teamwork”
[72] D. Orlemans, J.W.G., Eelen, P., Hermans, Inleiding tot de gedragstherapie. Bohn
Stafleu Van Loghum, 1997.
[73] I. M. Marks, Living with fear: Understanding and coping with anxiety. McGraw-
Hill, 1978.
[74] J. P. R. W. Trijsburg, M. Jelicic, W. W. van den Broek, J. E. M. Plekker, R. Verheij,
Gedragstherapeutische behandeling van naaldfobie,” Tijdschrift voor Psychotherapie, vol. 18, no. 6, pp. 215–222, 1992.


[75] de L. Horne DJ, McCormack H. Behavioural psychotherapy for a blood and needle phobic mastectomy patient receiving adjuvant chemotherapy. Behavioral Psychotherapy